Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Novartis Ag Sponsored ADR
(NVS US)
$151.12
-5.15
3.30%
Ext:
$157.00
+5.88
3.89%
(Market Closed · 00:00:04 UTC)
Follow
NVS US
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(1.2K)
Expand
6-K
Current report (foreign private issuer)
8 Sep
6-K
Current report (foreign private issuer)
4 Sep
6-K
Current report (foreign private issuer)
1 Sep
6-K
Current report (foreign private issuer)
21 Jul
6-K
Current report (foreign private issuer)
11 Jun
6-K
Current report (foreign private issuer)
28 Apr
6-K
Current report (foreign private issuer)
18 Mar
424B5
Prospectus filing (Rule 424(b)(5))
17 Mar
FWP
Free writing prospectus
16 Mar
424B5
Prospectus filing (Rule 424(b)(5))
16 Mar
S-8
Registration statement (employee benefit plan)
4 Feb
6-K
Current report (foreign private issuer)
4 Feb
6-K
Current report (foreign private issuer)
4 Feb
IRANNOTICE
IRANNOTICE
4 Feb
20-F
FY 2025
ended 31 Dec 2025
4 Feb
S-8 POS
Post-effective amendment (employee benefit plan)
16 Jan
S-8 POS
Post-effective amendment (employee benefit plan)
16 Jan
S-8 POS
Post-effective amendment (employee benefit plan)
16 Jan
S-8 POS
Post-effective amendment (employee benefit plan)
16 Jan
DFAN14A
Definitive additional soliciting materials
14 Jan
Ownership Filings
(196)
Expand
144
Bulto Carulla Victor
30 Apr
144
Marshall Fiona
12 Feb
144
Bulto Carulla Victor
9 Feb
3
NOVARTIS AG
28 Oct 2025
SC 13G
NOVARTIS AG
17 Jul 2025
144
Marshall Fiona
23 May 2025
144
Kowalski Robert William
30 Apr 2025
SC 13D/A
MorphoSys AG
17 Oct 2024
SC 13D/A
MorphoSys AG
15 Aug 2024
144
Kowalski Robert William
12 Aug 2024
SC 13D/A
MorphoSys AG
21 Jun 2024
SC 13D/A
MorphoSys AG
17 Jun 2024
SC 13D/A
MorphoSys AG
10 Jun 2024
SC 13D/A
MorphoSys AG
28 May 2024
144
Gal Aharon
22 May 2024
SC 13D
MorphoSys AG
18 Apr 2024
SC 13G/A
NOVARTIS AG
2 Feb 2024
144
Kowalski Robert William
19 Sep 2023
SC 13G/A
NOVARTIS AG
1 Feb 2023
3
NOVARTIS AG
27 Jun 2022
Ask in Filing